Editors-in-Chief
A. COSTE (Lausanne, Switzerland); C. HENNEQUIN (Paris, France); C. IMBERT (Poitiers, France)
Associate editors
V. AIMANIANDA (Paris, France); C. ALVAREZ MORENO (Bogota, Colombia); F. BOTTEREL (Créteil, France); L. BOUDESOCQUE-DELAYE (Tours, France); M. CORNET (Grenoble, France); F. DALLE (Dijon, France); E. DANNAOUI (Paris, France); G. DESOUBEAUX (Tours, France); G. GARCIA-EFFRON (Santa Fe, Argentina); M. GIRARDOT (Poitiers, France); A. GOMEZ-LOPEZ (Madrid, Spain); M. HENRIQUES (Braga, Portugal); S. IMBERT (Bordeaux, France); F. LANTERNIER (Paris, France); B. LMIMOUNI (Rabat, Maroc); L. MAMBU (Limoges, France); J. MENOTTI (Lyon, France); M. MILLOT (Limoges, France); T. NURYASTUTI (Yogyakarta, Indonesia); Rita O. OLADELE (Lagos, Nigeria); Shivaprakash M. RUDRAMURTHY (Chandigarh, India); F. RUZICKA (Brno, Czech Republic); P. SCHWARZ (Marburg, Germany); O.M. SEBOLAI (Bloemfontein, South Africa); S. ZNAIDI (Tunis, Tunisia)
Emeritus Editor-in-Chief
B. DUPONT (Paris, France)
Impact Factor: 3.6 (2022)
2023 Journal Citation Reports®, Clarivate Analytics
The Journal de Mycologie Médicale / Journal of Medical Mycology (JMM) publishes in English works dealing with human and animal mycology.
The subjects treated are focused in particular on clinical, diagnostic, epidemiological, immunological, medical, pathological, preventive or therapeutic aspects of mycoses.
Also covered are basic aspects linked primarily with morphology (electronic and photonic microscopy), physiology, biochemistry, cellular and molecular biology, immunochemistry, genetics, taxonomy or phylogeny of pathogenic or opportunistic fungi and actinomycetes in humans or animals. Studies of natural products showing inhibitory activity against pathogenic fungi cannot be considered without chemical characterization and identification of the compounds responsible for the inhibitory activity.
JMM publishes (guest) editorials, original articles, reviews (and minireviews), case reports, technical notes, letters to the editor and information. Only clinical cases with real originality (new species, new clinical present action, new geographical localization, etc.), and fully documented (identification methods, results, etc.), will be considered.
Under no circumstances does the Journal guarantee publication before the editorial board makes its final decision.
The Journal is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey Platforms.
Impact Factor: 3.6 (2022)
2023 Journal Citation Reports®, Clarivate Analytics
The Journal de Mycologie Médicale / Journal of Medical Mycology (JMM) publishes in English works dealing with human and animal mycology.
The subjects treated are focused in particular on clinical, diagnostic, epidemiological, immunological, medical, pathological, preventive or therapeutic aspects of mycoses.
Also covered are basic aspects linked primarily with morphology (electronic and photonic microscopy), physiology, biochemistry, cellular and molecular biology, immunochemistry, genetics, taxonomy or phylogeny of pathogenic or opportunistic fungi and actinomycetes in humans or animals. Studies of natural products showing inhibitory activity against pathogenic fungi cannot be considered without chemical characterization and identification of the compounds responsible for the inhibitory activity.
JMM publishes (guest) editorials, original articles, reviews (and minireviews), case reports, technical notes, letters to the editor and information. Only clinical cases with real originality (new species, new clinical present action, new geographical localization, etc.), and fully documented (identification methods, results, etc.), will be considered.
Under no circumstances does the Journal guarantee publication before the editorial board makes its final decision.
The Journal is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey Platforms.
EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.
En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.
Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.